Skip to main content
Rhonda Bitting, MD, Oncology, Winston Salem, NC

RhondaLBittingMD

Oncology Winston Salem, NC

Genitourinary Oncology

Medical Oncologist, Durham VA Healthcare System

Dr. Bitting is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bitting's full profile

Already have an account?

  • Office

    Medical Center Blvd Hematology and Oncology
    Winston Salem, NC 27157
    Phone+1 336-716-0327

Summary

  • Dr. Rhonda Bitting is an oncologist in Winston Salem, NC and is affiliated with Wake Forest Baptist Medical Center. She received her medical degree from Vanderbilt University School of Medicine and has been in practice 12 years. She specializes in genitourinary oncology and is experienced treating prostate, bladder, kidney and testicular cancers.

Education & Training

  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 2009 - 2012
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 2005 - 2008
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 2005

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2009 - 2025
  • CA State Medical License
    CA State Medical License 2006 - 2010
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Veracyte Announces That Findings Published in JCO Precision Oncology Suggest Potential of Decipher GRID-Derived Gene Signatures to Predict Treatment Response in Recurrent Prostate Cancer
    Veracyte Announces That Findings Published in JCO Precision Oncology Suggest Potential of Decipher GRID-Derived Gene Signatures to Predict Treatment Response in Recurrent Prostate CancerAugust 23rd, 2023
  • Analysis Group Researchers Identify Racial Disparities in Treatment of Metastatic Castration-Sensitive Prostate Cancer
    Analysis Group Researchers Identify Racial Disparities in Treatment of Metastatic Castration-Sensitive Prostate CancerApril 19th, 2024

Professional Memberships